These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 25894641)

  • 1. Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease.
    Lal D; Manocha S; Ray A; Vijayan VK; Kumar R
    J Basic Clin Physiol Pharmacol; 2015 Sep; 26(5):443-51. PubMed ID: 25894641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxofylline is not just another theophylline!
    Matera MG; Page C; Cazzola M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3487-3493. PubMed ID: 29255355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxofylline: a promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease.
    Shukla D; Chakraborty S; Singh S; Mishra B
    Expert Opin Pharmacother; 2009 Oct; 10(14):2343-56. PubMed ID: 19678793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of doxofylline in asthma and COPD.
    Cazzola M; Matera MG
    Respir Med; 2020 Apr; 164():105904. PubMed ID: 32094104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
    Goldstein MF; Chervinsky P
    Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study on the efficacy of tiotropium bromide inhalation and oral doxofylline treatment of moderate to severe stable chronic obstructive pulmonary disease.
    Wang T; Luo G; Hu Y; Li F; Ma J; Wang J; Zuo P; Xiong W; Liu X; Zhao J; Xiong S; Zhang Z; Li C; Zhao S; Sun J; Xu Y
    J Huazhong Univ Sci Technolog Med Sci; 2011 Oct; 31(5):614. PubMed ID: 22038349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of doxofylline in COPD: A pairwise meta-analysis.
    Cazzola M; Calzetta L; Rogliani P; Page C; Matera MG
    Pulm Pharmacol Ther; 2018 Aug; 51():1-9. PubMed ID: 29705620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of doxofylline compared to theophylline in asthma: A pooled analysis of functional and clinical outcomes from two multicentre, double-blind, randomized studies (DOROTHEO 1 and DOROTHEO 2).
    Calzetta L; Hanania NA; Dini FL; Goldstein MF; Fairweather WR; Howard WW; Cazzola M
    Pulm Pharmacol Ther; 2018 Dec; 53():20-26. PubMed ID: 30219705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long-term clinical trial on the efficacy and safety profile of doxofylline in Asthma: The LESDA study.
    Calzetta L; Matera MG; Goldstein MF; Fairweather WR; Howard WW; Cazzola M; Rogliani P
    Pulm Pharmacol Ther; 2020 Feb; 60():101883. PubMed ID: 31884206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of theophylline in treatment of asthma and chronic obstructive pulmonary disease].
    Xu YJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):319-22. PubMed ID: 15266839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD.
    Makino S; Adachi M; Ohta K; Kihara N; Nakajima S; Nishima S; Fukuda T; Miyamoto T; ;
    Allergol Int; 2006 Dec; 55(4):395-402. PubMed ID: 17130682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of moderate chronic obstructive pulmonary disease (stable) with doxofylline compared with slow release theophylline--a multicentre trial.
    Santra CK
    J Indian Med Assoc; 2008 Dec; 106(12):791-2, 794. PubMed ID: 19370950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Meta-analysis of efficacy and safety of oral theophylline in chronic obstructive pulmonary disease].
    Wang CH; Zhang Q; Li M; Fu PF; Yan ZM; Peng AM; Zhang GL
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(8):540-6. PubMed ID: 20367966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety profile of xanthines in COPD: a network meta-analysis.
    Cazzola M; Calzetta L; Barnes PJ; Criner GJ; Martinez FJ; Papi A; Gabriella Matera M
    Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29720510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on doxofylline injection in treatment of children with acute asthma attacks].
    Zhang JX; Lin HQ; Chen JS
    Zhonghua Er Ke Za Zhi; 2004 Feb; 42(2):143-4. PubMed ID: 15059495
    [No Abstract]   [Full Text] [Related]  

  • 16. Doxofylline: a new generation xanthine bronchodilator devoid of major cardiovascular adverse effects.
    Dini FL; Cogo R
    Curr Med Res Opin; 2001; 16(4):258-68. PubMed ID: 11268710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of doxofylline in the maintenance therapy of pediatric patients with bronchial asthma.
    Bagnato GF
    Eur Rev Med Pharmacol Sci; 1999; 3(6):255-60. PubMed ID: 11261736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of reversible chronic airways obstruction with doxofylline compared with slow-release theophylline: a double-blind, randomized, multicentre trial.
    Melillo G; Balzano G; Jodice F; De Felice A; Campisi V; Capone M; Di Filippo A; Foddai G; Franzone JS; Grossi E
    Int J Clin Pharmacol Res; 1989; 9(6):397-405. PubMed ID: 2699466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Theophylline in treatment of bronchial obstructive diseases].
    Rogala B
    Wiad Lek; 1998; 51(3-4):117-21. PubMed ID: 9658984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.